Oncomatryx, partner and coordinator of the NEXTOM project, visited Leitat’s facilities at the Parc Científic de Barcelona (PCB) for an in-person follow-up meeting on February 18. The project is currently at a crucial stage of development, and this meeting made it possible to review the most recent progress.
During the meeting, results obtained from candidate prototypes were presented, including molecular characterization, efficacy, and ADMEtox studies carried out by both entities. Thanks to these advances, the project continues to progress according to plan.
Following the meeting, participants had the opportunity to take a guided tour of Leitat’s facilities at the PCB. During the visit, they were able to discover first-hand the laboratories and technological capabilities, as well as the resources that Leitat makes available to projects to foster research and innovation in the field of health and biomedicine.
This meeting reaffirms the commitment of Oncomatryx and Leitat to innovation and collaboration, strengthening key partnerships and promoting knowledge transfer in the development of new oncological treatments.
Project CPP2023-010413 funded by:
